HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD – Trademark Portfolio
Entity Type: 16
HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include OMEMAX. The owner is based in HAIKOU, HAINAN.
ROOM 12B, 12TH FLOOR, UNIT 2, HAITIAN YISHE RESIDENTIAL BUILDING, NO. 9-2, YIXIN ROAD, RENMIN STREET, MEILAN DISTRICT
HAIKOU, HAINAN 570208 , CN
Showing of trademarks Trademarks
Trademark Classifications
HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD have?
HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD file in?
HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD's most well-known trademarks?
HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD's registered trademark portfolio includes well-known marks such as OMEMAX. These are among 1 currently registered trademark in the portfolio.
What is HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD's trademark registration success rate?
HAIKOU DAERYOU INTERNATIONAL BIOTECHNOLOGY CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.